5-chloro-2-methylphenyl acetate | 86297-37-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚酯
• 英文名称: 5-chloro-2-methylphenyl acetate
• 英文别名: p-Chlor-o-cresyl-acetat；(5-Chloro-2-methylphenyl) acetate
• CAS: 86297-37-2
• 化学式: C₉H₉ClO₂
• 分子量: 184.622
• InChiKey: DBCMBAJDUMIESM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-chloro-2-methylphenyl acetate 在 三氯化铝 作用下， 生成 1-(5-chloro-2-hydroxy-3-methylphenyl)ethanone
  参考文献：
  名称：

  Braude,M.B. et al., Journal of Organic Chemistry USSR (English Translation), 1973, vol. 9, p. 1927 - 1931

  摘要：

  DOI：
• 作为产物：
  描述：

  5-氯-2-甲基-2-硝基环己-3,5-二烯基乙酸酯 生成 5-chloro-2-methylphenyl acetate
  参考文献：
  名称：

  BAPAT, G. S.;FISCHER, A.;HENDERSON, G. N.;RAYMAHASAY, S., J. CHEM. SOC. CHEM. CUMMUN., 1983, N 3, 119-120

  摘要：

  DOI：

文献信息

• Antagonists of melanin concentrating hormone effects on the melanin concetrating hormone receptor
  申请人：——

  公开号：US20030229119A1

  公开（公告）日：2003-12-11

  The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.

  本发明涉及通过黑素浓缩激素受体对黑素浓缩激素（MCH）效果的拮抗，对于预防或治疗进食障碍、体重增加、肥胖、生殖和性行为异常、甲状腺激素分泌、利尿和水/电解质平衡、感觉处理、记忆、睡眠、觉醒、焦虑、抑郁、癫痫发作、神经退行性疾病和精神疾病是有用的。
• Electrophilic aromatic substitution. Part 30. The kinetics and products of the solvolyses in aqueous sulphuric acids of 5-chloro-2-methyl-2-nitrocyclohexa-3,5-dienyl acetate: the occurrence of A AC2 and A AL 1 solvolyses, and of an acid-catalysed elimination of nitrous acid, and the relationship of the A AL 1 solvolysis to the nitration of 4-chlorotoluene
  作者：Colin Bloomfield、Roy B. Moodie、Kenneth Schofield

  DOI：10.1039/p29830001793

  日期：——

  4-chloro-3-nitrotoluene comes from a thermal reaction of the diene unrelated to the elimination and solvolyses. The AAL1 reaction generates the ipso-Wheland intermediate (WiMe) that is also formed in the nitration of 4-chlorotoluene. The intermediate reacts by return to 4-chlorotoluene and nitronium ion (which can be captured by anisole), by 1,2- and 1,4-nucleophilic capture by water (giving 5-chloro-2-methylphenol

  上述命名二烯溶剂分解的良好的第一阶动力学在水中和在6.5-43.6％H 2 SO 4在25℃，并在水中和在15.2-58.8％H 2 SO 4在5℃下已经观察到。在此生产的4-氯甲苯，5-氯-2-甲基苯乙酸酯，5-氯-2-甲基苯酚，4-氯-2-硝基甲苯，4-氯-3-硝基甲苯和4-甲基-2-硝基苯酚的产率在磺胺酸或硫酸肼存在下，在25°C下水和21.5–92.4％H 2 SO 4中，以及还加入苯甲醚时，测定了2-和4-硝基苯甲醚的含量。溶剂分解通过酸催化的亚硝酸消除（在另一种情况下证实了初步结论1）），与A AC 2和A AL 1酯溶剂竞争。随着酸度的增加，溶剂分解作用占主导地位，A AL 1反应也越来越多。4-氯-3-硝基甲苯的少量收率来自与消除和溶剂分解无关的二烯的热反应。的甲AL 1个反应生成本位-Wheland中间体（w ^我我）也是在4-氯甲苯的硝化反应中形成的 中间体通过返回至4
• Synthesis of 3,4-Dihydro-2H-1,3-benzoxazine-2-thiones via Cyclization of 2-(1-Isothiocyanatoalkyl)phenols
  作者：Kazuhiro Kobayashi、Hiroki Inouchi、Naoki Matsumoto、Yuuki Chikazawa

  DOI：10.3987/com-15-s(t)2

  日期：——

  Convenient sequences for the preparation of 3,4-dihydro-2H-1,3-benzoxazine-2-thiones from 2-hydroxybenzaldehyde and 2-hydroxyphenyl ketones or 2-methylphenols have been developed, which both employ cyclization of 2-(1-isothiocyanatoalkyl)phenols generated in situ under mild conditions.
• US6818772B2
  申请人：——

  公开号：US6818772B2

  公开（公告）日：2004-11-16
• [EN] ANTAGONIST OF MELANIN CONCENTRATING HORMONE AND THEIR USES<br/>[FR] ANTAGONISTE DES EFFETS D'UNE HORMONE DE CONCENTRATION DE MELANINE ET SON UTILISATION
  申请人：ABBOTT LAB

  公开号：WO2003070244A1

  公开（公告）日：2003-08-28

  The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders. The present invention is directed to the compouds of formula (I).